96 related articles for article (PubMed ID: 23321522)
1. Longitudinal monitoring of sex-related in vivo metabolic changes in the brain of Alzheimer's disease transgenic mouse using magnetic resonance spectroscopy.
van Duijn S; Nabuurs RJ; van Duinen SG; Natté R; van Buchem MA; Alia A
J Alzheimers Dis; 2013; 34(4):1051-9. PubMed ID: 23321522
[TBL] [Abstract][Full Text] [Related]
2. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
[TBL] [Abstract][Full Text] [Related]
4. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.
Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M
J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382
[TBL] [Abstract][Full Text] [Related]
5. ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.
Doert A; Pilatus U; Zanella F; Müller WE; Eckert GP
J Neural Transm (Vienna); 2015 Apr; 122(4):541-50. PubMed ID: 25742870
[TBL] [Abstract][Full Text] [Related]
6. Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease.
Mlynárik V; Cacquevel M; Sun-Reimer L; Janssens S; Cudalbu C; Lei H; Schneider BL; Aebischer P; Gruetter R
J Alzheimers Dis; 2012; 31 Suppl 3():S87-99. PubMed ID: 22451319
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
[TBL] [Abstract][Full Text] [Related]
8. Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunization.
Marjańska M; Weigand SD; Preboske G; Wengenack TM; Chamberlain R; Curran GL; Poduslo JF; Garwood M; Kobayashi D; Lin JC; Jack CR
Neuroscience; 2014 Feb; 259():94-100. PubMed ID: 24316473
[TBL] [Abstract][Full Text] [Related]
9. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
[TBL] [Abstract][Full Text] [Related]
10. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span.
von Kienlin M; Künnecke B; Metzger F; Steiner G; Richards JG; Ozmen L; Jacobsen H; Loetscher H
Neurobiol Dis; 2005 Feb; 18(1):32-9. PubMed ID: 15649694
[TBL] [Abstract][Full Text] [Related]
11. Reduction of hippocampal N-acetyl aspartate level in aged APP(Swe)/PS1(dE9) transgenic mice is associated with degeneration of CA3 pyramidal neurons.
Xu W; Zhan Y; Huang W; Wang X; Zhang S; Lei H
J Neurosci Res; 2010 Nov; 88(14):3155-60. PubMed ID: 20806406
[TBL] [Abstract][Full Text] [Related]
12. APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI study.
Kuhla A; Rühlmann C; Lindner T; Polei S; Hadlich S; Krause BJ; Vollmar B; Teipel SJ
Neuroimage Clin; 2017; 15():581-586. PubMed ID: 28652970
[TBL] [Abstract][Full Text] [Related]
13. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
[TBL] [Abstract][Full Text] [Related]
14. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
15. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
[TBL] [Abstract][Full Text] [Related]
16. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
17. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
20. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
